Amarin Corporation plc (AMRN)
NASDAQ·Healthcare·Biotechnology
$11.57
-0.35%
Mkt Cap $301.56M
Analyst Ratings
No recent rating data.
Price Target (3 analysts)
$2.17
Range $1.50 – $3.00
Implied Upside
-81.2%
Consensus $2.17 vs current $11.57
NASDAQ·Healthcare·Biotechnology
$11.57
-0.35%
Mkt Cap $301.56M
No recent rating data.
Price Target (3 analysts)
$2.17
Range $1.50 – $3.00
-81.2%
Consensus $2.17 vs current $11.57